In the 1990s, more than 1 in 7 people died from breast cancer. Today, it’s 1 in 20. At Royal Surrey, it’s the second most treated cancer with over 2,700 treatments in the 12 months up to September 2026.
Treatment is provided by a large team of professionals from different disciplines who work incredibly hard to provide the best possible care to patients. October is Breast Cancer Awareness month, and the teams have been running events to emphasise the importance of checking for symptoms and highlighting the services offered at Royal Surrey.
Most referrals to the hospital come via GPs to the ‘One Stop Breast Clinic’ for examination, imaging and a biopsy if necessary. Our teams run three of these clinics every week, providing 87 new appointments.
Depending on results, patients will then be supported by one or more of our specialist teams. Olga Sueros-Velarde, Lead Breast Clinical Nurse Specialist, said: “Our multidisciplinary breast teams at Royal Surrey are truly dedicated to the management and care of people who have been diagnosed with breast cancer.”
Royal Surrey is the home of the Regional Breast Gene Carrier Service for those patients who’re identified as carrying a breast cancer gene. The Service runs a monthly clinic that brings together genetic counsellors, breast cancer specialist nurses, a clinical psychologist, gynaecologists, plastic surgeons and oncoplastic breast surgeons to support these people and help them reduce their risk of developing breast cancer. It’s also the only Trust in the region that offers a full Family History Assessment Service.
The teams are committed to leading innovation in breast cancer care and are piloting a bespoke digital platform for remote patient monitoring. The initiative aims to improve clinical productivity while providing patients with more personalised, convenient care and support.
The Trust also has an ongoing commitment to research through Royal Surrey’s Oncology Research team who run multiple breast cancer trials at any one time, with vital support from our patients. The trials, which aim to test the safety and effectiveness of new treatments, are mostly national or international research initiated by universities, other specialist hospitals and pharma lasting sometimes up to ten years.
Felicity Paterson, Consultant Oncologist and Joint Chief of Royal Surrey’s Oncology Service said:
“Breast cancer is not just one condition but has several different subtypes. Personalising therapy for each type of breast cancer starts with research trials. At Royal Surrey we are proud to be involved with a wide range of trials providing personalised care and a unique opportunity to our patients. We are incredibly grateful to all those who take part; by sharing their experiences and taking part in research, they’re helping to change the shape of future breast cancer care."
Breast Cancer Awareness month, held every year in October, is an opportunity to flag to people of all ages, one simple message: check, check and check again.
For further information go to our Breast cancer web pages, Breast Cancer Now or Coppafeel!
Two patients have shared their story of diagnosis and treatment.